Latest Stock Buy or Sell?
Make More Informed Decisions!

Today, Christine Poole commented about whether BAM.A-T, KKR-N, JPM-N, L-T, JNJ-N, AQN-T, EMA-T, BCE-T, BX-N, ENB-T, EMP.A-T, AC-T, C-N, MDLZ-Q, PPL-T, UL-N, ABT-N, PYPL-Q, PFE-N, BEP.UN-T, UNH-N, CVS-N, OTIS-N, TD-T, MSI-T, CAS-T are stocks to buy or sell.

COMMENT
While most stocks are flat or down, big tech has gotten ahead of themselves, so the recent sell-off was needed. Her picks today will be defensive. Ahead, there is Covid uncertainty with lockdowns possible and the looming U.S. election. Defensives include income stocks and consumer staples whose valuations are far more reasonable than the momentum stocks. We saw a very fast recovery this year. It's difficult to time the market. if you had sold at the (March) bottom, it's hard to chase and get back in. Six months after March, some highs have surpassed those March highs. She owns financially sound companies, even though their share prices may drop in the near term, but will ride out this storm and come out well in the end.
Unknown
PARTIAL SELL
Cascades Inc
A smaller cap name in paper and forestry. The tissue side has benefited from stay-at-home, but hotels aren't using as much tissue. The packaging business has enjoyed an increase with more packages needed for online shopping. However, this sector is cyclical, falling a lot if the market falls, though bouncing a lot if it rises. Cascades has performed quite well. Next year, supply is coming onstream in the container board business which have pressure pricing going forward. Take profits.
east coast forestry
HOLD
Morneau Shepell Inc
A human resource company that's fairly defensive. The price has come off some, but has held in well during the pandemic. Anchored by a steady income stream. They grow organically with some acquisitions. A hold. Defensive.
Business Services
BUY
Toronto Dominion

Canadian bank outlook The Canadian banks offer decent value though have lagged the overall market. The banks have provisioned in Q2 and Q3, and this level has likely peaked, so these levels should decline ahead. Look out for the next quarterly report, because the banks heavily warned about mortgages and commercial loans and many of these will start to roll off. The banks offer good dividend yields that she expects to hold. The banks entered the pandemic with strong capital and continued to strengthen it. She also own RY. Like this and TD. She'd buy both presently.

banks
BUY
Was a top pick recently. A leader in elevators, a oligopoly in this sector. They're diversified geographically. She has bought more shares, liking their recurring revenues. It's sort of defensive/industrial with opportunities for growth in China. Pays a 2% dividend. Good for long-term price appreciation.
machinery
COMMENT
CVS Health Corp

Regulations in the U.S. may affect distribution They recently bought health insurer Aetna. A cheap stock trading at 9x forward earnings. Not sure why the price has come off in the past month, maybe a rotation into momentum. The PBM business (https://en.wikipedia.org/wiki/Pharmacy_benefit_management) always has an overhang with the US government wanting to lower prices. These worries are absorbed into the CVS stock price. Also, CVS has had to pay more for PPE and labour wages, but these costs should abate in time. The current price reflects all these overhangs.

specialty stores
WEAK BUY
An excellent health operator. But if this crisis continues, employment levels may remain very low which could impact UNH. But UNH has probably seen the worst of the pandemic and this is a blue-chip name. Will be fine after this crisis, which she sees passing one day.
medical services
BUY ON WEAKNESS
The renewable sector offers great long-term secular growth and she's increasing her exposure. BEP is one of the biggest stocks in this space, and BEP operates globally. Offers attractive exposure to this space. Hold and buy on weakness.
Utilities
DON'T BUY
Pfizer Inc
Pfizer is having an analysts day this week. She owns another large pharma (see today's top picks). All the pharmas have said they won't make a lot of money on the vaccine in the first phase at least. They're still building a pipeline of drugs, so she doesn't own it.
biotechnology / pharmaceutical
COMMENT

She owns Visa in the digital payments instead, because they have the lowest-cost platform here. PYPL trades at a higher valuation. They really pulled back in the recent tech sell-off. This space offers long-term growth, so you need to own it.

0
PAST TOP PICK
Abbott Labs
(A Top Pick Sep 12/19, Up 28%) Still buying it around $102. It's a diversified healthcare company including nutritionals and generic drugs, the latter being sold to emerging markets. EM account for 40% of revenues. Medical devices was seeing fine product momentum even before Covid. After Covid, they've been producing testing kits which drives growth. They just announced a 5-minute test, boasting easy-to-use packaging, which will push growth. She expects excellent growth in the next few years, and it pays a solid dividend.
biotechnology / pharmaceutical
PAST TOP PICK
Unilever PLC

(A Top Pick Sep 12/19, Up 5%) Global consumer staples and defensive. Has long owned this. They're growing their personal care division, which offers high margins, and accounts for 40% of revenues. Dove, Lux and Tresemme are some of their brands. 60% of their revenues are free emerging markets, which she expects to grow long term. Near term, developed markets will remain strong because of pantry loading and customers gravitate to well-known brands. UL were able to leap from 2 to 60 factories making hand sanitizer. A consistent dividend grower.

food processing
PAST TOP PICK
(A Top Pick Sep 12/19, Down 30%) It got hit in the whole energy sell-off. An excellent pipeline name. In Q1, they pulled back capex plans to protect their dividend (8% is safe) and balance sheet. Most of their contracts are long-term, and their clients are investment-grade. A fine income stock.
pipelines
BUY

Like Unilever, is a global consumer, defensive name. MDLZ offers world-famous brands in snacks that have done well in this pandemic.

Consumer Products
DON'T BUY
Citigroup Inc.

She owns JP Morgan in US banks. They just announced a new CEO. They need to spend more on risk monitoring, which is strange so late in the day. This will drag on the recovery on their bottom line, because this spend will weigh on their expenses. Banks on both sides of the border are attractive. She prefers JPM because their managers are strong; they're the cream of the crop among US banks. JPM was very conservative in their provisions in the last few quarters. Will bounce back.

banks